首页 | 本学科首页   官方微博 | 高级检索  
检索        

Stathmin基因表达与肿瘤化疗药物敏感性的关系
引用本文:井晓荣,刘丽,赵辉,张惠中.Stathmin基因表达与肿瘤化疗药物敏感性的关系[J].第四军医大学学报,2005,26(9):784-788.
作者姓名:井晓荣  刘丽  赵辉  张惠中
作者单位:第四军医大学唐都医院临床实验科,陕西,西安,710038;第四军医大学唐都医院临床实验科,陕西,西安,710038;第四军医大学唐都医院临床实验科,陕西,西安,710038;第四军医大学唐都医院临床实验科,陕西,西安,710038
摘    要:目的:探讨8种肿瘤细胞对长春新碱(vincristine, VCR)和泰索帝(docetaxel, DOC)两种化疗药物的敏感性以及该敏感性与肿瘤细胞内Stathmin基因表达之间的关系. 方法:采用MTT法和形态学观察,根据两种药物对细胞的相对抑制率,分析8种肿瘤细胞对两种药物的敏感情况;应用实时荧光定量PCR技术分析比较上述细胞Stathmin基因表达情况. 结果: 8种肿瘤细胞对VCR的敏感程度(相对抑制率)依次为:骨肉瘤细胞9607,58%,9901, 56%;宫颈癌细胞Hela, 37%;肝癌细胞HHCC, 34%;肺癌细胞A549,31%;喉癌细胞Hep-2,17%;胃癌细胞MKN45, 16%;肝癌细胞7721,15%. 对DOC敏感程度依次为: 9607, 48%; Hela,46%;9901,44%;Hep-2, 34%;A549, 31%;MKN45,15%;HHCC, 12%;7721, 3%;Stathmin基因在各肿瘤细胞中具有不同程度的表达,其表达强度与各肿瘤细胞对两种药物的敏感性有关. 结论:肿瘤细胞中Statnmin基因表达水平与其化疗药物敏感程度有关,检测Statnmin基因表达水平对临床化疗药物的选择有一定的指导意义.

关 键 词:肿瘤细胞  长春新碱  泰索帝  MTT试验  抑制率  实时定量PCR
文章编号:1000-2790(2005)09-0784-05
修稿时间:2004年12月30

Relationship between expression of Stathmin gene in cancer cells and its sensitivity to chemotherapeutic drugs
JING Xiao-Rong,LIU Li,ZHAO Hui,ZHANG Hui-Zhong.Relationship between expression of Stathmin gene in cancer cells and its sensitivity to chemotherapeutic drugs[J].Journal of the Fourth Military Medical University,2005,26(9):784-788.
Authors:JING Xiao-Rong  LIU Li  ZHAO Hui  ZHANG Hui-Zhong
Abstract:AIM: To investigate the sensitivity of eight kinds of cancer cells to two kinds of chemotherapeutic drugs: Vincristine and Docetaxel and to study the relationship between the sensitivity and the expression of Stathmin gene in these cells. METHODS: The chemosensitivity of the eight kinds of cancer cells to Vincristine (VCR) and Docetaxel (DOC) was detected by MTT colorimetric assay and morphological observation. Real time PCR technology was used to examine the expression of Stathmin gene in these cells. RESULTS: The inhibition rates of the eight kinds of cancer cells by VCR and DOC were respectively 58% and 48% for human osteosarcoma cells line Sosp-9607 (9607), 56% and 44% for human osteosarcoma cells line Sosp-9901 (9901), 37% and 46% for cervical cancer cells line Hela (Hela), 34% and 12% for human hepatocellular carcinoma cells line HHCC (HHCC), 31% and 31% for lung cancer cells line A549 (A549), 17% and 34% for largngo-carcinoma cells line Hep-2 (Hep-2), 16% and 15% for gastric cancer cells line MKN45 (MKN45), and 15% and 3% for human hepatocelluar carcinoma cells line 7721 (7721) cells. The intensity of the expression of Stathmin gene in the eight kinds of cells was different and was correlated with the sensitivity mentioned above. CONCLUSION: The expression of Stathmin gene in cancer cells is related to its sensitivity to the chemotherapeutic drugs. The detection of the expression of Stathmin gene in tumor cells may be of some clinical significance in choosing a chemotherapy agent.
Keywords:cancer cells  Vincristine  Docetaxel  MTT assay  inhibition  real time PCR
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号